Impact of augmented-reality improvement in ablation catheter navigation as assessed by virtual-heart simulations of ventricular tachycardia ablation
Recently, an augmented reality (AR) solution allows the physician to place the ablation catheter at the designated lesion site more accurately during cardiac electrophysiology studies. The improvement in navigation accuracy may positively affect ventricular tachycardia (VT) ablation termination, how...
Gespeichert in:
Veröffentlicht in: | Computers in biology and medicine 2021-06, Vol.133, p.104366-104366, Article 104366 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Recently, an augmented reality (AR) solution allows the physician to place the ablation catheter at the designated lesion site more accurately during cardiac electrophysiology studies. The improvement in navigation accuracy may positively affect ventricular tachycardia (VT) ablation termination, however assessment of this in the clinic would be difficult. Novel personalized virtual heart technology enables non-invasive identification of optimal lesion targets for infarct-related VT. This study aims to evaluate the potential impact of such catheter navigation accuracy improvement in virtual VT ablations.
2 MRI-based virtual hearts with 2 in silico induced VTs (VT 1, VT 2) were included. VTs were terminated with virtual “ground truth” endocardial ablation lesions. 106 navigation error values that were previously assessed in a clinical study evaluating the improvement of ablation catheter navigation accuracy guided with AR (53 with, 53 without) were used to displace the “ground truth” ablation targets. The corresponding ablations were simulated based on these errors and VT termination for each simulation was assessed.
In 54 VT 1 ablation simulations, smaller error with AR significantly resulted in more VT termination (25) compared to the error without AR (16) (P |
---|---|
ISSN: | 0010-4825 1879-0534 |
DOI: | 10.1016/j.compbiomed.2021.104366 |